Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Comparison of ESWT and Single-Session 5% Dextrose Prolotherapy in Lateral Epicondylitis

NCT: NCT07620678 · COMPLETED

NCT IDNCT07620678
StatusCOMPLETED
Start Date2023-10-01
Completion2025-08-29
SponsorGaziler Physical Medicine and Rehabilitation Education and Research Hospital (OTHER)
First posted
Last updated

Brief Summary

Lateral epicondylitis is a common musculoskeletal disorder associated with pain and impaired upper extremity function. The aim of this study was to compare the effectiveness of extracorporeal shock wave therapy (ESWT) and single-session 5% dextrose prolotherapy (DPT) in patients with lateral epicondylitis and to evaluate the relative superiority of these treatment approaches during short- and mid-to-long-term follow-up. Ninety-six patients were allocated into three groups: conventional treatment alone, conventional treatment plus ESWT, and conventional treatment plus DPT. Pain, functional status, grip strength, and common extensor tendon thickness were evaluated during follow-up.

Frequently Asked Questions

What is Comparison of ESWT and Single-Session 5% Dextrose Prolotherapy in Lateral Epicondylitis?

Comparison of ESWT and Single-Session 5% Dextrose Prolotherapy in Lateral Epicondylitis is a clinical trial registered under NCT07620678. Current status: COMPLETED.

What is the status of NCT07620678?

The current status of NCT07620678 (Comparison of ESWT and Single-Session 5% Dextrose Prolotherapy in Lateral Epicondylitis) is: COMPLETED.

When did Comparison of ESWT and Single-Session 5% Dextrose Prolotherapy in Lateral Epicondylitis start?

Comparison of ESWT and Single-Session 5% Dextrose Prolotherapy in Lateral Epicondylitis started on 2023-10-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.